|
GB9816837D0
(en)
|
1998-08-04 |
1998-09-30 |
Zeneca Ltd |
Amide derivatives
|
|
WO1999054286A2
(en)
|
1998-04-17 |
1999-10-28 |
Parker Hughes Institute |
Btk inhibitors and methods for their identification and use
|
|
CN1142912C
(zh)
|
1998-08-04 |
2004-03-24 |
阿斯特拉曾尼卡有限公司 |
用作细胞因子产生的抑制剂的酰胺衍生物
|
|
ES2211172T3
(es)
|
1998-09-25 |
2004-07-01 |
Astrazeneca Ab |
Derivados de benzamida y su utilizacion como inhibidores de citoquinas.
|
|
US6306897B1
(en)
|
1999-03-19 |
2001-10-23 |
Parker Hughes Institute |
Calanolides for inhibiting BTK
|
|
US6921763B2
(en)
|
1999-09-17 |
2005-07-26 |
Abbott Laboratories |
Pyrazolopyrimidines as therapeutic agents
|
|
KR20020088406A
(ko)
|
1999-09-17 |
2002-11-27 |
애보트 게엠베하 운트 콤파니 카게 |
치료제로서의 피라졸로피리미딘
|
|
ES2367422T3
(es)
|
2001-10-09 |
2011-11-03 |
Amgen Inc. |
Derivados de imidazol como agentes antiinflamatorios.
|
|
CA2495386C
(en)
|
2002-08-14 |
2011-06-21 |
Vertex Pharmaceuticals Incorporated |
Protein kinase inhibitors and uses thereof
|
|
ATE500837T1
(de)
|
2002-12-05 |
2011-03-15 |
Univ Arkansas |
Molekulare determinanten des multiplen myeloms und deren verwendung
|
|
JP4896518B2
(ja)
|
2002-12-13 |
2012-03-14 |
ワイエム・バイオサイエンシズ・オーストラリア・ピーティーワイ・リミテッド |
ニコチンアミド系キナーゼ阻害薬
|
|
BRPI0418031A
(pt)
|
2003-12-22 |
2007-04-17 |
Gilead Sciences Inc |
inibidores de quinase fosfonato-substituìdos
|
|
TW200616974A
(en)
|
2004-07-01 |
2006-06-01 |
Astrazeneca Ab |
Chemical compounds
|
|
PE20060664A1
(es)
|
2004-09-15 |
2006-08-04 |
Novartis Ag |
Amidas biciclicas como inhibidores de cinasa
|
|
EP1828246A1
(en)
|
2004-12-20 |
2007-09-05 |
SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. |
Myd88 homodimerization inhibitors
|
|
AR053992A1
(es)
|
2004-12-22 |
2007-05-30 |
Astrazeneca Ab |
Compuestos quimicos con actividad anticancerosa, un procedimiento para su preparacion, su uso en la preparacion de medicamentos y composicion farmaceutica.
|
|
MX2007007574A
(es)
|
2004-12-22 |
2007-07-24 |
Astrazeneca Ab |
Derivados de piridina-carboxamida para uso como agentes anticancerosos.
|
|
JP2008528585A
(ja)
|
2005-01-26 |
2008-07-31 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
タンパク質キナーゼ阻害剤としての化合物および組成物
|
|
CN101277689B
(zh)
|
2005-08-08 |
2011-01-12 |
詹森药业有限公司 |
噻唑并嘧啶类激酶抑制剂
|
|
US7754717B2
(en)
|
2005-08-15 |
2010-07-13 |
Amgen Inc. |
Bis-aryl amide compounds and methods of use
|
|
GT200600411A
(es)
|
2005-09-13 |
2007-05-21 |
Novartis Ag |
Combinaciones que comprenden un inhibidor del receptor del factor de crecimiento endotelial vascular
|
|
WO2007059157A1
(en)
|
2005-11-14 |
2007-05-24 |
Genentech, Inc. |
Bisamide inhibitors of hedgehog signaling
|
|
JP2009520784A
(ja)
|
2005-12-22 |
2009-05-28 |
アストラゼネカ アクチボラグ |
キナゾリン誘導体、その製造方法および抗癌剤としてのその使用
|
|
WO2007076474A1
(en)
|
2005-12-23 |
2007-07-05 |
Kalypsys, Inc. |
Novel substituted pyridinyloxy and pyrimidinyloxy amides useful as inhibitors of protein kinases
|
|
GB0605120D0
(en)
|
2006-03-14 |
2006-04-26 |
Novartis Ag |
Organic Compounds
|
|
US20090312396A1
(en)
*
|
2006-07-10 |
2009-12-17 |
Astrazeneca Ab |
Methods for cancer treatment using tak1 inhibitors
|
|
PL2526933T3
(pl)
|
2006-09-22 |
2015-08-31 |
Pharmacyclics Llc |
Inhibitory kinazy tyrozynowej Brutona
|
|
ES2625798T3
(es)
|
2006-10-02 |
2017-07-20 |
E. R. Squibb & Sons, L.L.C. |
Anticuerpos humanos que se unen a CXCR4 y usos de los mismos
|
|
US20120065201A1
(en)
|
2007-03-28 |
2012-03-15 |
Pharmacyclics, Inc. |
Inhibitors of bruton's tyrosine kinase
|
|
MX2009011207A
(es)
|
2007-04-17 |
2009-12-07 |
Novartis Ag |
Eteres de amidas de acido naftalen-carboxilico como cura para el cancer.
|
|
WO2008144253A1
(en)
|
2007-05-14 |
2008-11-27 |
Irm Llc |
Protein kinase inhibitors and methods for using thereof
|
|
TW200906825A
(en)
|
2007-05-30 |
2009-02-16 |
Scripps Research Inst |
Inhibitors of protein kinases
|
|
US7928140B2
(en)
|
2007-08-02 |
2011-04-19 |
Amgen Inc. |
Benzothiazole PI3 kinase modulators for cancer treatment
|
|
US7982036B2
(en)
*
|
2007-10-19 |
2011-07-19 |
Avila Therapeutics, Inc. |
4,6-disubstitued pyrimidines useful as kinase inhibitors
|
|
US7989465B2
(en)
|
2007-10-19 |
2011-08-02 |
Avila Therapeutics, Inc. |
4,6-disubstituted pyrimidines useful as kinase inhibitors
|
|
KR20100058660A
(ko)
|
2007-10-23 |
2010-06-03 |
테바 파마슈티컬 인더스트리즈 리미티드 |
다사티닙 다형체 및 이의 제조 방법
|
|
US8394816B2
(en)
|
2007-12-07 |
2013-03-12 |
Irene Ghobrial |
Methods of using [3.2.0] heterocyclic compounds and analogs thereof in treating Waldenstrom's Macroglobulinemia
|
|
ES2396366T3
(es)
|
2007-12-10 |
2013-02-21 |
Concert Pharmaceuticals Inc. |
Inhibidores heterocíclicos de quinasas
|
|
JP5529852B2
(ja)
|
2008-05-06 |
2014-06-25 |
ジリード コネティカット，インコーポレイティド |
置換アミド、その製造法及びＢｔｋインヒビターとしての使用
|
|
NZ603525A
(en)
*
|
2008-06-27 |
2015-02-27 |
Celgene Avilomics Res Inc |
Pyrimidine based compound and uses thereof
|
|
US7824861B2
(en)
|
2008-07-10 |
2010-11-02 |
National Tsing Hua University |
Method for quantitative analysis of transcripts with nucleotide polymorphism at specific site
|
|
PL3081552T3
(pl)
|
2008-08-13 |
2021-12-20 |
Mitsui Chemicals Agro, Inc. |
Środek do zwalczania szkodników zawierający pochodną amidową i zastosowanie środka do zwalczania szkodników
|
|
EP2331506B1
(de)
*
|
2008-09-02 |
2013-07-03 |
Boehringer Ingelheim International GmbH |
Neue benzamide, deren herstellung und deren verwendung als arzneimittel
|
|
US8598174B2
(en)
|
2008-11-12 |
2013-12-03 |
Genetech, Inc. |
Pyridazinones, method of making, and method of use thereof
|
|
SG172355A1
(en)
|
2008-12-23 |
2011-07-28 |
Genentech Inc |
Methods and compositions for diagnostic use in cancer patients
|
|
US8614234B2
(en)
*
|
2009-09-03 |
2013-12-24 |
Allergan, Inc. |
Compounds as tyrosine kinase modulators
|
|
WO2011029043A1
(en)
|
2009-09-04 |
2011-03-10 |
Biogen Idec Ma Inc. |
Heteroaryl btk inhibitors
|
|
EP2937345B1
(en)
*
|
2009-12-29 |
2018-03-21 |
Dana-Farber Cancer Institute, Inc. |
Type ii raf kinase inhibitors
|
|
KR101661383B1
(ko)
|
2010-02-08 |
2016-09-29 |
머크 샤프 앤 도메 비.브이. |
8-메틸-1-페닐-이미다졸［1,5-ａ］피라진 화합물
|
|
US20120071497A1
(en)
|
2010-06-03 |
2012-03-22 |
Pharmacyclics, Inc. |
Methods of treating abc-dlbcl using inhibitors of bruton's tyrosine kinase
|
|
CN102985426B
(zh)
|
2010-07-13 |
2015-10-07 |
弗·哈夫曼-拉罗切有限公司 |
作为irak4调节剂的吡唑并[1,5a]嘧啶和噻吩并[3,2b]嘧啶衍生物
|
|
EP2638018A1
(en)
*
|
2010-11-09 |
2013-09-18 |
Cellzome Limited |
Pyridine compounds and aza analogues thereof as tyk2 inhibitors
|
|
EP2640366A2
(en)
|
2010-11-15 |
2013-09-25 |
Exelixis, Inc. |
Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture
|
|
CA2832605C
(en)
|
2011-05-23 |
2016-03-29 |
Merck Patent Gmbh |
Pyridine-and pyrazine derivatives
|
|
EA031153B1
(ru)
*
|
2011-06-10 |
2018-11-30 |
Мерк Патент Гмбх |
Применение пиримидиновых соединений с btk ингибирующей активностью
|
|
ES2624981T3
(es)
|
2011-07-01 |
2017-07-18 |
Dana-Farber Cancer Institute, Inc. |
Descubrimiento de una mutación somática en el gen MYD88 en linfoma linfoplasmocitario
|
|
EP2548877A1
(en)
|
2011-07-19 |
2013-01-23 |
MSD Oss B.V. |
4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors
|
|
US9023873B2
(en)
|
2011-10-03 |
2015-05-05 |
Syngenta Participations Ag |
Insecticidal 2-methoxybenzamide derivatives
|
|
AU2012318580A1
(en)
|
2011-10-04 |
2014-05-22 |
Gilead Calistoga Llc |
Novel quinoxaline inhibitors of PI3K
|
|
EA027561B1
(ru)
|
2011-11-03 |
2017-08-31 |
Ф.Хоффманн-Ля Рош Аг |
Алкилированные соединения пиперазина в качестве ингибиторов тирозинкиназы брутона
|
|
SI2776032T1
(sl)
|
2011-11-09 |
2018-12-31 |
Bristol-Myers Squibb Company |
Zdravljenje hematoloških malignih obolenj z anti-CXCR4 protitelesom
|
|
WO2013074986A1
(en)
|
2011-11-17 |
2013-05-23 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of c-jun-n-terminal kinase (jnk)
|
|
JP6117235B2
(ja)
|
2011-12-15 |
2017-04-19 |
ノバルティス アーゲー |
Ｐｉ３ｋの活性または機能の阻害剤の使用
|
|
US9604988B2
(en)
|
2012-07-27 |
2017-03-28 |
Riken |
Agent for treating or inhibiting recurrence of acute myeloid leukemia
|
|
CN103405429A
(zh)
|
2013-08-22 |
2013-11-27 |
中国药科大学 |
一类vegfr-2抑制剂及其用途
|
|
CA3206628A1
(en)
|
2013-09-12 |
2015-03-19 |
Dana-Farber Cancer Institute, Inc. |
Methods for evaluating and treating waldenstrom's macroglobulinemia
|
|
WO2015069287A1
(en)
*
|
2013-11-08 |
2015-05-14 |
Allergan, Inc. |
Compounds as tyrosine kinase modulators
|
|
US10612095B2
(en)
|
2013-12-06 |
2020-04-07 |
Dana-Farber Cancer Institute, Inc. |
Methods to distinguish Waldenström's Macroglobulinemia from IgM monoclonal gammopathy of undetermined significance
|
|
JP6878004B2
(ja)
|
2013-12-13 |
2021-05-26 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
リンパ形質細胞性リンパ腫を処置する方法
|
|
JP6879740B2
(ja)
|
2013-12-13 |
2021-06-02 |
ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド |
リンパ形質細胞性リンパ腫を処置する方法
|
|
WO2016055982A1
(en)
|
2014-10-10 |
2016-04-14 |
Acerta Pharma B.V. |
Quinoline and quinazoline compounds
|
|
US10112957B2
(en)
|
2014-10-22 |
2018-10-30 |
Dana-Farber Cancer Institute, Inc. |
Thiazolyl-containing compounds for treating proliferative diseases
|
|
CA3103604C
(en)
|
2016-03-28 |
2023-09-26 |
Presage Biosciences, Inc. |
Pharmaceutical combinations for the treatment of cancer
|
|
WO2017189999A1
(en)
|
2016-04-29 |
2017-11-02 |
Dana-Farber Cancer Institute, Inc. |
Hck as a therapeutic target in myd88 mutated diseases
|
|
CN106008371A
(zh)
|
2016-06-24 |
2016-10-12 |
谢阳 |
1-芳基脲基环烷基-1-甲酰胺类化合物及其药物组合物和应用
|
|
CN106279120A
(zh)
|
2016-07-15 |
2017-01-04 |
谢阳 |
一种n‑芳基氨基甲酰基脯氨酸类化合物及其药物组合物和应用
|
|
CN107056786B
(zh)
|
2016-10-14 |
2019-05-07 |
苏州明锐医药科技有限公司 |
阿卡替尼的制备方法
|
|
JP2021506735A
(ja)
|
2017-05-26 |
2021-02-22 |
イクノス サイエンシズ エスエー |
新規ｍａｐ４ｋ１阻害剤
|
|
KR20220098732A
(ko)
|
2019-10-08 |
2022-07-12 |
다나-파버 캔서 인스티튜트 인크. |
요법, 특히 myd88 돌연변이된 질환에 사용하기 위한 hck 억제제로서의 피라졸로피리미딘 유도체
|
|
WO2021071919A1
(en)
|
2019-10-08 |
2021-04-15 |
Dana-Farber Cancer Institute, Inc. |
Hck as a therapeutic target in myd88 mutated diseases
|